according to a statement released by the government agency.On Thursday, an advisory panel met with Pfizer representatives to review data from its drug trials conducted this year.The trials found that the drug was 95% effective at preventing serious cases of COVID-19 and that the drug was “well-tolerated,” Pfizer said.RELATED: US advisory panel OKs Pfizer vaccine in last step before FDA approvalThursday’s advisory panel endorsed Pfizer’s vaccine candidate.The FDA said it has notified the Centers for Disease Control and Prevention and Operation Warp Speed of its plan so “they can execute their plans for timely vaccine distribution.”AdvertisementAn illustration picture shows vials with Covid-19 Vaccine stickers attached and medical syringe.